IlluminavsJohnson & Johnson

ILMN and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

ILMN

Illumina, Inc.

$210.01

Value $32.1B

+3.65%
ILMN's page

Illumina (ILMN) has a market value of $32.1B and Johnson & Johnson (JNJ) $657B. Over the last year, with dividends, ILMN moved +74.9% and JNJ +39.7%. The P/E is 35.9 for ILMN and 40.8 for JNJ. Dividend yield: ILMN none, JNJ 1.94%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ILMN$32.1B

    JNJ$657B

    JNJ is 20 times ILMN

  • Revenue, 12 months

    ILMN$4.5B

    JNJ$99.3B

    JNJ is 22 times ILMN

  • Net income, 12 months

    ILMN$895M

    JNJ$16.1B

    JNJ is 18 times ILMN

  • Operating margin

    ILMN21.2%

    JNJ–

  • ROIC

    ILMN17.3%

    JNJ12.4%

    4.9 points apart

  • P/E

    ILMN35.9

    JNJ40.8

    JNJ is 1.1 times ILMN

  • Dividend yield

    ILMN0.0%

    JNJ1.9%

    1.9 points apart

  • 5-year return

    ILMN-42.8%

    JNJ+92.0%

    134.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ILMN-42.8%

JNJ+92.0%

10020020222023202420252026
Returns by period
PeriodILMNWith dividendsJNJWith dividends
1 year since November 17, 2025+74.9%Price +74.9%+39.7%Price +36.6%
3 years since November 17, 2023+128.9%+31.8% a yearPrice +128.9%+98.2%+25.6% a yearPrice +82.1%
5 years since November 17, 2021-42.8%-10.6% a yearPrice -42.8%+92.0%+13.9% a yearPrice +67.0%
10 years since November 18, 2016+63.7%+5.1% a yearPrice +63.7%+208.0%+11.9% a yearPrice +136.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ILMNIlluminaJNJJohnson & Johnson

Valuation

ILMNJNJ
Valuation
Price$210.01$272.70
Market value$32.1B$657B
Enterprise value (EV)$32.6B$685B
P/E35.940.8
P/E, 5-year median–21.9
P/B10.28.1
EV/EBIT33.938.6
Free cash flow yield3.3%3.1%

Results and growth

ILMNJNJ
Results and growth
Revenue, 12 months$4.5B$99.3B
Net income, 12 months$895M$16.1B
Free cash flow, 12 months$1.1B$20.6B
Earnings per share, 12 months$5.81$6.59
Revenue growth, year on year-0.7%6.1%
Revenue growth a year, past+6.0%over 5 years+2.7%over 5 years
EPS growth a year, past+4.1%over 5 years+14.9%over 5 years

Margins and returns on capital

ILMNJNJ
Margins and returns on capital
Gross margin67.9%67.6%
Operating margin21.2%–
Net margin19.7%16.2%
ROIC17.3%12.4%
ROE32.5%19.7%

Balance sheet

ILMNJNJ
Balance sheet
Cash$1.3B$17.2B
Total debt$2.3B$44.7B
Net debt / EBITDA0.41.1
Interest cover9.8×18.0×

Dividends and buybacks

ILMNJNJ
Dividends and buybacks
Dividend yield–1.9%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield2.3%0.9%
Shareholder yield2.3%2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ILMN or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Illumina or Johnson & Johnson?

By market value, Johnson & Johnson ($657B) is about 20.5 times Illumina ($32.1B), at today's prices.

How did ILMN and JNJ stock do over the last 10 years?

Since November 18, 2016, ILMN's price moved +63.7% and JNJ's +136.4%. With dividends: ILMN +63.7% (+5.1% a year), JNJ +208.0% (+11.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, ILMN or JNJ?

The dividend yield at today's price is none for Illumina and 1.94% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

What is the P/E of ILMN and JNJ?

At today's price, the P/E is 35.9 for ILMN and 40.8 for JNJ. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Illumina or Johnson & Johnson?

Over the last twelve months, the net margin was 19.7% for Illumina and 16.2% for Johnson & Johnson, and the operating margin 21.2% and –. Revenue was $4.5B and $99.3B.

Which is the better investment, Illumina or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.